Vaibhav Oberoi¹* and Ashish Sarangi²

¹Department of Neurology, Government Medical College and Hospital, Amritsar, Punjab, India
²Department of Psychiatry, University of Missouri, Columbia, MO, USA

*Corresponding Author: Vaibhav Oberoi, Department of Neurology, Government Medical College and Hospital, Amritsar, Punjab, India.

Received: August 07, 2024; Published: August 31, 2024

Citation: Vaibhav Oberoi and Ashish Sarangi. “Addressing the Complexities of Post-Stroke Psychiatric Disorders”. Acta Scientific Neurology 7.9 (2024): 21-22.

In comprehensive stroke care, the focus historically has been on physical rehabilitation and preventing secondary cardiovascular events. However, the growing recognition of post-stroke psychiatric disorders, as highlighted in recent comprehensive reviews and studies, highlights the urgent need for a paradigm shift in stroke management. Beyond physical weakness, stroke survivors often suffer from a range of psychiatric ailments such as depression, anxiety, cognitive impairment, psychosis, and even rare conditions like post-stroke mania and delirium. These conditions not only impair quality of life but also complicate rehabilitation efforts and increase the risk of recurrent stroke [1-7].

The prevalence rates alone paint a stark picture: post-stroke depression affects approximately 27% of survivors at any time point post-stroke, while anxiety disorders and cognitive impairment are also distressingly common [5,8]. These psychiatric sequelae can arise acutely or develop over time, influenced by a wide array of factors including genetic predispositions, neurobiological changes, and environmental stressors. Understanding the interplay of these factors is crucial for effective interventions.

The need for comprehensive care

Traditional stroke care pathways must expand to encompass comprehensive psychiatric assessments and targeted interventions. Early identification using validated screening tools like the 4-AT for delirium or structured psychiatric interventions including exposure therapy, and CBT, for anxiety disorders is essential [5,9]. Timely interventions, whether pharmacological or non-pharmacological, can significantly mitigate the impact of these disorders on patients’ lives.

Advancements in treatment approaches

Recent research highlights promising treatment modalities. Pharmacologically, SSRIs, SNRIs, and mood stabilizers show efficacy in managing post-stroke depression and mania [10,11]. Acetylcholinesterase inhibitors are beneficial for cognitive impairment, while antipsychotics like risperidone and quetiapine are used to manage post-stroke psychosis [7,12]. Nonpharmacological approaches such as acupuncture, tai chi, and even virtual reality therapy are emerging as valuable adjuncts or alternatives, addressing both mental and physical rehabilitation needs [13-15].

Challenges and future directions

Despite these advancements, challenges remain. Research gaps persist, particularly in understanding the precise mechanisms underlying these psychiatric disorders post-stroke and validating optimal treatment algorithms. Also, disparities in access to specialized psychiatric care and the integration of these services into stroke rehabilitation programs must be addressed.

Holistic care models that incorporate multidisciplinary teams comprising neurologists, psychiatrists, rehabilitation specialists, and social workers are significant. Such collaborative efforts ensure that stroke survivors receive not only medical treatments, but also psychosocial support, rehabilitation, and long-term care planning tailored to their individual needs.

Conclusion

As we navigate the complexities of post-stroke psychiatric disorders, ongoing research initiatives and concerted clinical efforts are crucial. By advancing our understanding and refining treatment approaches, we can significantly improve outcomes and enhance the quality of life for stroke survivors. The integration of psychiatric care into routine stroke management protocols represents a pivotal step towards achieving holistic and patientcentered care. Ultimately, addressing the multifaceted challenges posed by these disorders requires a united effort across disciplines, guided by empathy, innovation, and a commitment to improving the lives of those affected by stroke.

These editorial aims to highlight the critical importance of recognizing and addressing post-stroke psychiatric disorders in clinical practice, underscoring the need for integrated care pathways and ongoing research to optimize patient outcomes.

Bibliography

1. Amytis Towfighi BONEHMLHREJBMKPHMLESMAWLSW. Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association”. Stroke 48.2 (2017): e30-e42.
2. Jule Filler., et al. “Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis”. The Lancet Healthy Longevity1 (2024): e31-e44.
3. Sarah T Pendlebury DPhil a PMRFm a. “Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis”. The Lancet Neurology 11 (2009): 1006-1018.
4. Susan Mahon., et al. “Determinants, Prevalence, and Trajectory of Long-Term Post-Stroke Cognitive Impairment: Results from a 4-Year Follow-Up of the ARCOS-IV Study”. Neuroepidemiology 3-4 (2017): 129-134.
5. Ho-Yan Yvonne Chun., et al. “Anxiety After Stroke: The Importance of Subtyping”. Stroke3 (2018): 556-564.
6. Henrique Nascimento. “Psychotic Disorder after Left Posterior Cerebral Artery Stroke-An Atypical Event”. Actas Españolas de Psiquiatría 1 (2024): 60-65.
7. Helle Stangeland and Vasiliki Orgeta.
8. Lu Liu. “Prevalence and natural history of depression after stroke: A systematic review and meta-analysis of observational studies”. PLOS Medicine3 (2023): e1004200.
9. Irene Mansutti LS. “Detecting delirium in patients with acute stroke: a systematic review of test accuracy”. BMC Neurology 310 (2019).
10. Shaojiong Zhou B., et al. “Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke”. Medicine 6 (2020).
11. Dmitry Frank., et al. “Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review”. International Journal of Molecular Sciences 23 (2022): 15114.
12. Jin Ok Kim SJLSJL. “Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis”. PLoS One2 (2020): e0227820.
13. Xue Wang., et al. “Meta-analysis of the clinical effectiveness of combined acupuncture and Western Medicine to treat poststroke depression”. Journal of Traditional Chinese Medicine 6 (2021): 6-16.
14. Qian Cai., et al. “Tai Chi for anxiety and depression symptoms in cancer, stroke, heart failure, and chronic obstructive pulmonary disease: A systematic review and meta-analysis” Complementary Therapies in Clinical Practice 46 (2022):
15. Hebing Liu ZCSW and YJ. “Effects of virtual reality-based intervention on depression in stroke patients: a metaanalysis”. Scientific Reports (2023).

Copyright: © 2024 Vaibhav Oberoi and Ashish Sarangi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.